Holen Sie sich die Stockscreener-App
25.00
1.34%
-0.34
Handel nachbörslich:
24.75
-0.25
-1.00%
Schlusskurs vom Vortag:
$25.34
Offen:
$23.81
24-Stunden-Volumen:
461.15K
Relative Volume:
29.28
Marktkapitalisierung:
$1.10B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$23.81
$25.50
1-Wochen-Bereich:
$23.81
$32.00
52-Wochen-Spanne:
$23.81
$32.00
Hemab Therapeutics Holdings Inc Stock (COAG) Company Profile
Firmenname
Hemab Therapeutics Holdings Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare COAG vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COAG
Hemab Therapeutics Holdings Inc
|
25.00 | 1.12B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Hemab Therapeutics Holdings Inc Aktie (COAG) Neueste Nachrichten
Hemab, Seaport surge as clinical-stage biotechs make trading debuts - MSN
COAG Technical Analysis & Stock Price Forecast - Intellectia AI
Novo-backed biotech Hemab seeks to raise $212 million in US IPO - MSN
Hemab Therapeutics closes upsized IPO raising $346.7 million - Investing.com
COAG News Today | Why did Hemab Therapeutics stock go down today? - MarketBeat
Hemab Therapeutics closes $346.7 million IPO on Nasdaq - Investing.com UK
Hemab Therapeutics closes $346.7 million IPO on Nasdaq By Investing.com - Investing.com India
Hemab Therapeutics closes upsized IPO raising $346.7 million By Investing.com - Investing.com South Africa
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Hemab Therapeutics Holdings Inc. (COAG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Hemab's stock market debut brings in $346.7M after banks buy more shares - Stock Titan
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Number of employees of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Hemab Therapeutics Holdings, Inc (COAG) Stock Price Today & Analysis - Gotrade
Novo-backed biotech Hemab raises $301.5 million in upsized IPO - MSN
Free float of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Hemab Therapeutics (COAG) Stock Trends and Sentiment 2026 - MarketBeat
Hemab Therapeutics (COAG) 10K Form and Latest SEC Filings 2026 - MarketBeat
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Seaport, Hemab price upsized IPOs, eyeing $550M in proceeds - MSN
symbol__ Stock Quote Price and Forecast - CNN
COAG (Hemab Therapeutics Holdings) Cyclically Adjusted PS R - GuruFocus
COAG Price Today: Hemab Therapeutics Holdings, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Hemab Therapeutics IPO Debut Puts COAG And Pipeline Risks In Focus - Yahoo Finance
COAG Price History for Hemab Therapeutics Holdings Stock - Barchart.com
COAG Price Today: Hemab Therapeutics Holdings, Inc. Stock Price, Quote & Chart - MEXC Exchange
Latest Hemab Therapeutics Holdings, Inc. Common Stock Stock News & COAG Headlines - CoinCodex
Hemab Therapeutics Boosts IPO to 15 Million Shares From 11.8 Million - Moomoo
COAG Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
COAG Should I Buy - Intellectia AI
COAG PE Ratio & Valuation, Is COAG Overvalued - Intellectia AI
COAG News & Events - Intellectia AI
COAG Forecast — Price Prediction for 2026. Should I Buy COAG? - Intellectia AI
COAG Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Hemab, Seaport surge on trading debuts (SPTX:NASDAQ) - Seeking Alpha
Hemab Therapeutics Holdings' 16.8M-Share IPO Prices at $18 a Share - Moomoo
Hemab prices $301M in latest upsized biopharma IPO - BioWorld News
Seaport, Hemab price upsized IPOs eyeing $550M in proceeds - Seeking Alpha
Hemab Therapeutics sets terms for $200 million IPO - The Pharma Letter
COAG|Hemab Therapeutics Holdings Ord Shs (Proposed)|Price:34.280| - TradingKey
Hemab Therapeutics prices IPO at $18 per share By Investing.com - Investing.com Canada
Hemab Therapeutics prices IPO at $18 per share - Investing.com UK
EBITDA of Hemab Therapeutics Holdings Inc. – NASDAQ:COAG - TradingView
Working capital per share of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Diluted shares outstanding of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Total revenue of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Dilution adjustment of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Non-controlling/minority interest of Hemab Therapeutics Holdings Inc. – NASDAQ:COAG - TradingView
Cash from operating activities of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Taxes of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Discontinued operations of Hemab Therapeutics Holdings Inc. – NASDAQ:COAG - TradingView
Finanzdaten der Hemab Therapeutics Holdings Inc-Aktie (COAG)
Es liegen keine Finanzdaten für Hemab Therapeutics Holdings Inc (COAG) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):